Press Coverage
Hepatitis C Treatment: Study Finds No Liver, Kidney or Cardiovascular Adverse Effects
Interview mentions that an ISMP QuarterWatchTM report raising questions about whether direct acting antiviral medications for the treatment of Hepatitis C posed any significant safety risks for patients was the impetus for further study.
For the full text, visit MedicalResearch.com online.
More News
Regularly scheduled boosters are the most effective way to maintain normalcy in an endemic
New Recommendations Focus on Safe Use of Technology
This article from Kaiser Health News appeared on the CNN website on April 28, 2022.